What's New
| Newsletters BTK inhibitors in CLL and MCL: Strategies for Managing Adverse Events Julie M. Vose, MD, MB; Jeremy R. Stone, MD; Nicole Lamanna, MD; Peter Campbell, PharmD, BCOP |
| CE Education Multidisciplinary Perspectives on BTK Inhibitors Adverse Events Management in CLL and MCL Julie M. Vose, MD, MB – Chair; Jeremy R. Stone, MD; Nicole Lamanna, MD; Peter Campbell, PharmD, BCOP |
| Newsletters Caring for Patients with CLL in Rural America Satish Shanbhag, MD, MPH, FACP |
| CE Education BTK inhibitors in CLL and MCL: Strategies for Managing Adverse Events Farrukh T. Awan, MD; Alan Morgan, MPA; Opal H. Greenway, JD |
| Newsletters The Epidemiology of CLL in Rural America Gary G. Schwartz, PhD, MPH |